Colony-stimulating factors for febrile neutropenia [7]

New England Journal of Medicine

Volumn 369, Issue 3, 2013, Pages 285-

  Buti, Sebastiano ^a   Sikokis, Angelica ^a   Ardizzoni, Andrea ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; EVIDENCE BASED MEDICINE; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT INDICATION; FEMALE; NEOPLASM; NEUTROPENIA; NOTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; NEOPLASMS; NEUTROPENIA;

EID: 84880437803     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1306109     Document Type: Letter

References (4)

1. Cooper KL, Madan J, Whyte S, Stevenson MD, Akehurst RL. Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. BMC Cancer 2011;11:404.
2. Clark OA, Lyman GH, Castro AA, Clark LG, Djulbegovic B. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials. J Clin Oncol 2005;23:4198-214. (Pubitemid 46211326)
3. Kuderer NM, Dale DC, Crawford J, Lyman GH. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 2007;25:3158-67. (Pubitemid 47218066)
4. Lyman GH, Dale DC, Wolff DA, et al. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-timulating factor: a systematic review. J Clin Oncol 2010;28:2914-24.